Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8667531 | Journal of the American Society of Hypertension | 2017 | 5 Pages |
Abstract
Prehypertension (systolic blood pressure 120-139 or diastolic blood pressure 80-89Â mm Hg) confers a risk of progression to hypertension, impairment of cognitive function, increased left ventricular mass, risk of end-stage renal disease, and an association with arteriosclerosis. Recent studies provide data that could support the rationale for treating prehypertensives subjects with antihypertensive medications in addition to lifestyle modification, especially if they have concomitant cardiovascular risk factors.
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Barry J. MD, MBA, Manuel MD, Stephane B. MD, Richard A. MD, MBA, MSPH,